Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
1.410
+0.030 (2.17%)
At close: Dec 5, 2025, 4:00 PM EST
1.410
0.00 (-0.02%)
After-hours: Dec 5, 2025, 7:59 PM EST
Tenaya Therapeutics Stock Forecast
TNYA's stock price has decreased by -58.77% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Tenaya Therapeutics stock have an average target of 8.60, with a low estimate of 5.00 and a high estimate of 18. The average target predicts an increase of 509.93% from the current stock price of 1.41.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tenaya Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +538.30% | Nov 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +254.61% | Sep 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +254.61% | Aug 27, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +538.30% | Aug 7, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +538.30% | May 9, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
4.08M
EPS This Year
-0.67
from -1.31
EPS Next Year
-0.58
from -0.67
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | 21.0M | ||||
| Avg | n/a | 4.1M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.64 | -0.54 | ||||
| Avg | -0.67 | -0.58 | ||||
| Low | -0.73 | -0.60 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.